Genetics of autoimmune diseases in humans and in animal models

Current Opinion in Immunology

Volumn 14, Issue 6, 2002, Pages 803-811

  Morahan, Grant ^a   Morel, Laurence ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT CYTOKINE;

AUTOIMMUNE DISEASE; CONGENIC STRAIN; CROHN DISEASE; GENE CLUSTER; GENE IDENTIFICATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; CHROMOSOME MAP; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; MOUSE; RAT;

ANIMALS; AUTOIMMUNE DISEASES; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MICE; MICE, CONGENIC; RATS;

EID: 0036888516     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00401-6     Document Type: Review

References (67)

1. Altmuller J., Palmer L.J., Fischer G., Scherb H., Wjst M. Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet. 69:2001;936-950. A meta-analysis of genome scans, highlighting the importance of large datasets and reduced genetic heterogeneity in successfully mapping genes in complex traits.
2. Cox N.J., Wapelhorst B., Morrison V.A., Johnson L., Pinchuk L., Spielman R.S., Todd J.A., Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet. 69:2001;820-830. The largest genome scan reported thus far for T1D. Increased sample size is able to reveal a locus of hitherto weak effect, with the trade-off that loci defined previously within the same families were 'lost' when tested separately. Were these loci really false positives or is increased genetic/environmental heterogeneity to blame?
3. Nerup J., Pociot F. A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet. 69:2001;1301-1313. This is an important report of a T1D genome scan on a relatively homogeneous dataset. Highlighting the challenge of finding genes involved in complex traits, the loci that were reported from other scans (including IDDM2/INS) were not found in these Scandinavian families, but new loci were revealed.
4. Morahan G., Huang D., Ymer S.I., Cancilla M.R., Stephen K., Dabadghao P., Werther G., Tait B.D., Harrison L.C., Colman P.G. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet. 27:2001;218-221. This paper reports mapping of a new T1D locus (IDDM18) and shows that polymorphisms in the IL12B gene, a strong candidate within the region, shows strong association with disease susceptibility in two independent sets of families. Cell lines of different genotypes showed different IL12B expression levels.
5. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., Presky D.H. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol. 16:1998;495-521.
6. Adorini L., Gregori S., Harrison L.C. Understanding autoimmune diabetes: insights from mouse models. Trends in Molecular Medicine. 8:2002;31-38. An excellent review of the pathogenesis of T1D arising from the use of NOD and other mouse models.
7. Huang D., Cancilla M.R., Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun. 1:2000;515-520.
8. Bergholdt R., Morahan G., Johannesen J. Linkage disequilibrium of an interleukin-12 polymorphism (IDDM18) in Danish Type 1 diabetes families. Diabetologia. 44:(Suppl):2002;202.
9. Davoodi-Semiromi A., Yang J.J., She J.X. IL-12p40 Is associated with type 1 diabetes in caucasian-american families. Diabetes. 51:2002;2334-2336. This study shows confirmation of a role for IL12B in T1D. In contrast to [4••], a different polymorphism was found to be associated with susceptibility, which suggests that the true causative polymorphism in/near this gene remains to be found. These authors also showed variation in IL12B gene expression, according to IL12B genotype, in non-transformed cells.
10. van Veen T., Crusius J.B., Schrijver H.M., Bouma G., Killestein J., van Winsen L., Salvador Pena A., Polman C.H., Uitdehaag B.M. Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol. 50:2001;275.
11. Morahan G, Boutlis CB, Huang D, Pain A, Saunders JR, Hobbs MR, Granger DL, Weinberg JB, Peshu N, Mwaikambo ED et al.: A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes and Immunity 2002, in press. This paper extends the influence of IL12B to another polymorphism and another disease. A polymorphism in the IL12B promoter was shown to be associated with death from cerebral malaria in Tanzanian children.
12. Price P, Morahan G, Huang D, Stone E, Cheong KYM, Castley A, Rodgers M, Abraham L, Jones M, French MA: Polymorphisms in cytokine genes may define sub-populations of HIV-1 Patients who are susceptible to particular Immune Restoration Diseases when they begin anti-retroviral therapy. AIDS 2002, in press. Another disease associated with IL12B polymorphisms.
13. Ymer S.I., Huang D., Penna G., Gregori S., Branson K., Adorini L., Morahan G. Polymorphisms in the Il12b gene affect structure and expression of IL- 12 in NOD and other autoimmune-prone mouse strains. Genes Immun. 3:2002;151-157. Alleles and haplotypes of the mouse Il12b gene were defined, and these were also found to be associated with differences in gene expression. In contrast to the human orthologue, mouse Il12b has alleles that have amino acid substitutions, one of which defines an antibody-binding site and was illustrated on a three dimensional model.
14. Pugliese A., Miceli D. The insulin gene in diabetes. Diabetes Metab Res Rev. 18:2002;13-25.
15. Vafiadis P., Ounissi-Benkalha H., Palumbo M., Grabs R., Rousseau M., Goodyer C.G., Polychronakos C. Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocrinol Metab. 86:2001;3705-3710. Further evidence that the INS/IDDM2 effect is mediated through differential thymic expression.
16. Chentoufi A.A., Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes. 51:2002;1383-1390.
17. Kristiansen O.P., Larsen Z.M., Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun. 1:2000;170-184.
18. Tomer Y., Greenberg D.A., Barbesino G., Concepcion E., Davies T.F. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab. 86:2001;1687-1693.
19. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol. 165:2000;6606-6611.
20. Huang D., Giscombe R., Zhou Y., Pirskanen R., Lefvert A.K. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper- reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol. 105:2000;69-77.
21. Holopainen P.M., Partanen J.A. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol. 167:2001;2457-2458.
22. Graham J., Hagopian W.A., Kockum I., Li L.S., Sanjeevi C.B., Lowe R.M., Schaefer J.B., Zarghami M., Day H.L., Landin-Olsson M., et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes. 51:2002;1346-1355. A systematic comparison of the effects of genotypes at the three best associated T1D susceptibility genes (HLA, INS, CTLA4) on progression through islet autoimmunity to T1D. This type of analysis will provide the data for future estimates of risk based on risk factors such as age, genotype and gender.
23. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603. Identification of a positional candidate gene involved in Crohn's disease susceptibility.
24. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606. Identification of a positional candidate gene involved in Crohn's disease susceptibility.
25. Wanstrat A., Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nature Immunology. 2:2001;802-809. An excellent review of murine models of autoimmunity.
26. Morel L., Blenman K.R., Croker B.P., Wakeland E.K. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci USA. 98:2001;1787-1792.
27. Lie B.A., Sollid L.M., Ascher H., Ek J., Akselsen H.E., Ronningen K.S., Thorsby E., Undlien D.E. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens. 54:1999;162-168.
28. Oka A., Tamiya G., Tomizawa M., Ota M., Katsuyama Y., Makino S., Shiina T., Yoshitome M., Iizuka M., Sasao Y., et al. Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet. 8:1999;2165-2170.
29. Cheong K.Y., Allcock R.J., Eerligh P., Witt C.S., Christiansen F.T., McCann V., Price P. Localization of central MHC genes influencing type I diabetes. Hum Immunol. 62:2001;1363-1370.
30. Zavattari P., Lampis R., Motzo C., Loddo M., Mulargia A., Whalen M., Maioli M., Angius E., Todd J.A., Cucca F. Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum Mol Genet. 10:2001;881-889.
31. Gambelunghe G., Ghaderi M., Tortoioli C., Falorni A., Santeusanio F., Brunetti P., Sanjeevi C.B. Two distinct MICA gene markers discriminate major autoimmune diabetes types. J Clin Endocrinol Metab. 86:2001;3754-3760.
32. Boulard O., Damotte D., Deruytter N., Fluteau G., Carnaud C., Garchon H.J. An interval tightly linked to but distinct from the h2 complex controls both overt diabetes (idd16) and chronic experimental autoimmune thyroiditis (ceat1) in nonobese diabetic mice. Diabetes. 51:2002;2141-2147.
33. Morahan G., Huang D., Tait B.D., Colman P.G., Harrison L.C. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science. 272:1996;1181-1183.
34. Merriman T.R., Cordell H.J., Eaves I.A., Danoy P.A., Coraddu F., Barber R., Cucca F., Broadley S., Sawcer S., Compston A., et al. Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes. 50:2001;184-194. A good example of how genetic information acquired in multiple diseases and species can be used. By pooling data from several diseases the authors were able to show that a single locus, with an initial relatively weak effect in each system, contributes to multiple autoimmune diseases.
35. Johansson A.C., Sundler M., Kjellen P., Johannesson M., Cook A., Lindqvist A.K., Nakken B., Bolstad A.I., Jonsson R., Alarcon-Riquelme M., et al. Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcgammaRIIb and is not associated with loci controlling diabetes. Eur J Immunol. 31:2001;1847-1856.
36. Barton A., Eyre S., Myerscough A., Brintnell B., Ward D., Ollier W.E., Lorentzen J.C., Klareskog L., Silman A., John S., et al. High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis. Hum Mol Genet. 10:2001;1901-1906.
37. Morel L., Croker B.P., Blenman K.R., Mohan C., Huang G., Gilkeson G., Wakeland E.K. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA. 97:2000;6670-6675.
38. Bolland S., Yim Y.S., Tus K., Wakeland E.K., Ravetch J.V. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med. 195:2002;1167-1174.
39. Lyons P.A., Armitage N., Lord C.J., Phillips M.S., Todd J.A., Peterson L.B., Wicker L.S. Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse. Diabetes. 50:2001;2633-2637.
40. Fraser C.C., Howie D., Morra M., Qiu Y., Murphy C., Shen Q., Gutierrez-Ramos J.C., Coyle A., Kingsbury G.A., Terhorst C. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family. Immunogenetics. 53:2002;843-850.
41. Rioux J.D., Daly M.J., Silverberg M.S., Lindblad K., Steinhart H., Cohen Z., Delmonte T., Kocher K., Miller K., Guschwan S., et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet. 29:2001;223-228. This analysis proposes that a cluster of cytokine genes, rather than a single gene, confers Crohn's disease susceptibility.
42. Rozzo S.J., Allard J.D., Choubey D., Vyse T.J., Izui S., Peltz G., Kotzin B.L. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity. 15:2001;435-443. Identification of an interferon-inducible gene as a candidate for SLE susceptibility comparing gene expression profiles between congenic strains using microarrays.
43. Hamilton-Williams E.E., Serreze D.V., Charlton B., Johnson E.A., Marron M.P., Mullbacher A., Slattery R.M. Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proc Natl Acad Sci USA. 98:2001;11533-11538. An elegant demonstration of the role of β2m as a T1D susceptibility gene: the only non-MHC autoimmune candidate gene that has so far been validated by allele transgenesis.
44. Boackle S.A., Holers V.M., Chen X., Szakonyi G., Karp D.R., Wakeland E.K., Morel L. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity. 15:2001;775-785. Identification of a complement receptor as an SLE candidate gene, providing potential insights on the role of complement in SLE.
45. Morel L., Tian X.H., Croker B.P., Wakeland E.K. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity. 11:1999;131-139.
46. Graser R.T., DiLorenzo T.P., Wang F., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., Serreze D.V. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol. 164:2000;3913-3918.
47. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., Baxter A.G. NKT cells: facts, functions and fallacies. Immunol Today. 21:2000;573-583.
48. Barrington R., Zhang M., Fischer M., Carroll M.C. The role of complement in inflammation and adaptive immunity. Immunol Rev. 180:2001;5-15.
49. Choubey D., Kotzin B.L. Interferon-inducible p202 in the susceptibility to systemic lupus. Front Biosci. 7:2002;e252-e262.
50. Benoist C., Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol. 2:2001;797-801.
51. Tangye S.G., Phillips J.H., Lanier L.L. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin Immunol. 12:2000;149-157.
52. MacMurray A.J., Moralejo D.H., Kwitek A.E., Rutledge E.A., Van Yserloo B., Gohlke P., Speros S.J., Snyder B., Schaefer J., Bieg S., et al. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res. 10:2002;1029-1039. Identification by positional cloning of a novel gene responsible for a Mendelian trait associated with T1D in the BB rat.
53. Hornum L., Romer J., Markholst H. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes. 51:2002;1972-1979. Identification by positional cloning of a novel gene responsible for a Mendelian trait associated with T1D in the BB rat.
54. Wakeland E.K., Liu K., Graham R.R., Behrens T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 15:2001;397-408.
55. Murga M., Fernandez-Capetillo O., Field S.J., Moreno B., Borlado L.R., Fujiwara Y., Balomenos D., Vicario A., Carrera A.C., Orkin S.H., et al. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity. 15:2001;959-970.
56. Salvador J.M., Hollander M.C., Nguyen A.T., Kopp J.B., Barisoni L., Moore J.K., Ashwell J.D., Fornace A.J. Jr. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity. 16:2002;499-508.
57. Miyamoto A., Nakayama K., Imaki H., Hirose S., Jiang Y., Abe M., Tsukiyama T., Nagahama H., Ohno S., Hatakeyama S., Nakayama K.I. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature. 416:2002;865-869.
58. Zhang Y., Schlossman S.F., Edwards R.A., Ou C.N., Gu J., Wu M.X. Impaired apoptosis, extended duration of immune responses, and a lupus- like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci USA. 99:2002;878-883.
59. Santiago-Raber M.L., Lawson B.R., Dummer W., Barnhouse M., Koundouris S., Wilson C.B., Kono D.H., Theofilopoulos A.N. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol. 167:2001;4067-4074.
60. Leiter E.H. Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. Diabetologia. 45:2002;296-308. An excellent review of the use of genetically modified mice and the specific challenges they pose to data interpretation. Importantly, suggested solutions are proposed to avoid future problems in the use of these models.
61. Boyton R.J., Altmann D.M. Transgenic models of autoimmune disease. Clin Exp Immunol. 127:2002;4-11.
62. Nelms K.A., Goodnow C.C. Genome-wide ENU mutagenesis to reveal immune regulators. Immunity. 15:2001;409-418. An excellent overview of an ENU mutagenesis project directed at the identification of genes involved in immune regulation.
63. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 8:2002;500-508. The first microarray analysis of a human autoimmune disease, the results of which are specifically powerful because of their validation in the EAE animal models.
64. Ibrahim S.M., Mix E., Bottcher T., Koczan D., Gold R., Rolfs A., Thiesen H.J. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain. 124:2001;1927-1938.
65. Pritchard C.C., Hsu L., Delrow J., Nelson P.S. Project normal: defining normal variance in mouse gene expression. Proc Natl Acad Sci USA. 98:2001;13266-13271.
66. Smyth GK, Yang YH, Speed TP: Statistical issues in microarray data analysis. In Functional Genomics: Methods and Protocols, Methods in Molecular Biology Series. Edited by Brownstein MJ, Khodursky AB. Humana Press; 2002, in press.Now in pressThe work referred to in the text as (G Morahan, D Huang, M Wu, unpublished data) is now in press:
67. Morahan G., Huang D., Wu M., Holt B.J., White G.P., Kendall G.E., Sly P.D., Holt P.G. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet. 360:2002;455-459. This paper demonstrates that another disease of immune dysregulation, childhood asthma, is associated with an IL12B promoter polymorphism resulting in lower gene expression. Children with the risk genotype are nearly five times more likely to develop severe asthma, which can be of either allergic or intrinsic type. Thus, the same polymorphism contributes to disease severity via different immunological mechanisms, each of which is dependent on lower IL-12 production.